🇺🇸 FDA
Pipeline program

Yinhu Qingwen Granula

YHQW-Severe-V2.0

Phase 3 small_molecule on_hold

Quick answer

Yinhu Qingwen Granula for COVID-19 is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
COVID-19
Phase
Phase 3
Modality
small_molecule
Status
on_hold

Clinical trials